These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8518036)

  • 1. Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma.
    Di Bartolomeo M; Zampino MG; Di Leo A; Bajetta E
    Eur J Cancer; 1993; 29A(8):1215-6. PubMed ID: 8518036
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
    Barone C; Cassano A; Astone A; Ricevuto E; Fontana T; Noviello MR; Garufi C; Pacelli F; Grieco A
    Oncology; 1991; 48(5):353-5. PubMed ID: 1745479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic adenocarcinoma responding to cisplatin based cytotoxic chemotherapy.
    Marshall E; Trotter JM; Metcalf C
    Aust N Z J Med; 1991 Oct; 21(5):780-1. PubMed ID: 1722092
    [No Abstract]   [Full Text] [Related]  

  • 4. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer.
    González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacon I; Garrido P; Colmenarejo A
    Eur J Cancer; 1994; 30A(11):1733-4. PubMed ID: 7833158
    [No Abstract]   [Full Text] [Related]  

  • 5. Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
    Abad A; Masuti B; Camps C; Font A; Balañá C; Vicent JM; Sánchez JJ
    Eur J Cancer; 1994; 30A(7):1043. PubMed ID: 7946573
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer.
    Costa MA; Lamarca JE; Bader GR
    Eur J Cancer; 1994; 30A(6):891. PubMed ID: 7917557
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
    Adenis A
    Bull Cancer; 1994 Apr; 81(4):331-3. PubMed ID: 7703551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group.
    Wils J; Bleiberg H; Buyse M; Wagener DT; Splinter T; Veenhof C; Herben M; Duez N
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1119-20. PubMed ID: 2759166
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
    Evans TR; Lofts FJ; Mansi JL; Glees JP; Dalgleish AG; Knight MJ
    Br J Cancer; 1996 May; 73(10):1260-4. PubMed ID: 8630289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
    Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
    Içli F; Celik I; Aykan F; Uner A; Demirkazik A; Ozet A; Ozgüroğlu M; Taş F; Akbulut H; Firat D
    Cancer; 1998 Dec; 83(12):2475-80. PubMed ID: 9874451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation.
    Chao Y; Teng HC; Hung HC; King KL; Li CP; Chi KH; Yen SH; Chang FY
    Jpn J Clin Oncol; 2000 Mar; 30(3):122-5. PubMed ID: 10798538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
    Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P
    Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Le Péchoux C; Arriagada R; Le Chevalier T
    Cancer; 1995 Aug; 76(3):530-1. PubMed ID: 8625139
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
    Panetta A; Angelelli B; Martoni A
    Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide.
    Morant R; Bruckner HW
    Cancer; 1989 Nov; 64(10):2007-9. PubMed ID: 2553237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma".
    Piver MS
    Cancer Treat Rep; 1986 Dec; 70(12):1466. PubMed ID: 3791262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.